Open Label Study to Assess Long-term Safety of Repeat Administration of Botulinum Toxin Type A for Moderate to Severe Crow's Feet Lines

Inclusion Criteria: * Moderate to severe crow's feet lines * Female or male, 18 years of age and above and in good general health * Women of childbearing potential must agree to use an effective method of birth control during the course of the study Exclusion Criteria: * Any neurological condition that may place the subject at increased risk with exposure to botulinum toxin type A * Muscle weakness or paralysis, particularly in the area receiving study treatment * Active skin disease or irritation at the treatment area * Deep dermal scarring, or inability to smooth out the crow's feet lines to be treated by manually spreading the skin apart * Treatment with botulinum toxin type A for crow's feet lines in the last 3 months * Chemical peel during the 9 months prior to treatment * Use of prescription retinoid products during the 3 months prior to treatment